Skip to main content

Advertisement

Table 1 Demographic data of the eight participants with RA and individual pre- and post-acupuncture self-reported assessments

From: The McMaster Toronto Arthritis patient preference questionnaire (MACTAR): a methodological study of reliability and minimal detectable change after a 6 week-period of acupuncture treatment in patients with rheumatoid arthritis

ID Gender Age, years RA duration, years Living situation Work/sick leave Medication MACTAR median 1 and 2, A-phase MACTAR VAS pain, 0–100 VAS, 0–100
Well-being
A1 A2 B1 B10 B1 B10 B1 B10
1 F 68 2 Living with partner Retired Coxa, Dmardb 45 43 43 41 69 75 76 70
2 M 56 1.5 Living with partner Work 20% Dmardb 54 54 54 60 43 49 43 42
3 F 63 10 Living alone Sick-leave 100% Dmardb, TNFc, kortisond 52 52 55 65 29 10 30 15
4 F 57 2.5 Living with partner Work 100% Dmardb 55 56 56 47 38 57 17 60
5 F 54 6 Living alone Work 50% Dmardb 40 52 56 62 49 50 34 51
6 M 65 24 Living with partner Work 75% Coxa, Dmardb 54 55 55 63 18 9 17 10
7 M 63 30 Living with partner Sick-leave 100% Coxa, TNFc 54 52 50 56 8 10 16 11
8 F 30 20 Living with partner Work 50% Coxa 44 43 44 65 62 42 71 35
  1. B1 first assessment during the B-phase, B10 last assessment in the B-phase after 10 acupuncture treatments
  2. aCyclooxygenase inhibitor (COX-inhibitor)
  3. 2Disease modifying anti rheumatic drugs (DMARD)
  4. 3Tumor necrosis factor (TNF-inhibitor)
  5. 4Glucocorticoids (prednisolone)